Clarity Pharmaceuticals Ltd (CLRPF)
OTCMKTS
· Delayed Price · Currency is USD
1.640
0.00 (0.00%)
Jul 3, 2025, 4:00 PM EDT
Clarity Pharmaceuticals Revenue
Clarity Pharmaceuticals had revenue of 4.69M AUD in the half year ending December 31, 2024, a decrease of -18.22%. This brings the company's revenue in the last twelve months to 10.78M, up 13.61% year-over-year. In the fiscal year ending June 30, 2024, Clarity Pharmaceuticals had annual revenue of 11.51M with 17.41% growth.
Revenue (ttm)
10.78M AUD
Revenue Growth
+13.61%
P/S Ratio
93.38
Revenue / Employee
215.54K AUD
Employees
50
Market Cap
622.80M USD
Revenue Chart
* This company reports financials in AUD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 84.04M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |